Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium vs No NMBA in Thyroid Surgery with IONM
NCT03910504Completed
- Start
- Apr 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of rocuronium in thyroid diseases (2 arms). Primary endpoint: Occurrence of absent or weak signal at V1 and R1. Started Apr 2019; status: completed.
02
Drugs
rocuronium
03
Conditions
thyroid diseases
Beyond the preview
Go deeper on NCT03910504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03910504.